SEBACEOUS HYPERPLASIA
CLINICAL OVERVIEW & PROCEDURAL MANAGEMENT
Sebaceous hyperplasia is a benign condition caused by enlargement of sebaceous (oil) glands. It most commonly appears as small, soft, yellowish or flesh-colored bumps on the face, particularly the forehead, cheeks, and nose.
These lesions are not harmful, but they may increase in number over time and are frequently mistaken for other skin growths. Because sebaceous hyperplasia originates from deep glandular structures, treatment requires careful technique selection to balance effectiveness with cosmetic outcome.
CLINICAL EVALUATION
Evaluation begins with focused clinical examination and, when appropriate, dermoscopic assessment. Key factors considered include:
- Lesion size, depth, and number
- Distribution and anatomic location
- Stability versus progression
- Skin type and healing characteristics
- Diagnostic certainty
While many lesions have a classic appearance, some require additional evaluation to confirm diagnosis before treatment is selected.
SEBACEOUS HYPERPLASIA VS. BASAL CELL CARCINOMA
Sebaceous hyperplasia and basal cell carcinoma (BCC) can occasionally appear similar on visual inspection, particularly when lesions are:
- Flesh-colored or yellowish
- Located on sun-exposed facial skin
- Slowly enlarging
Sebaceous hyperplasia is benign and does not behave like skin cancer.
When appearance is atypical or diagnostic certainty is needed, medical
evaluation—and in select cases biopsy—helps ensure accurate
diagnosis before treatment.
WHY SEBACEOUS HYPERPLASIA IS DIFFICULT TO TREAT
Sebaceous hyperplasia is challenging because the visible bump represents only part of the lesion. In many cases, the enlarged gland extends deeper beneath the skin surface.
Treatment may be limited by:
- Deep glandular components
- Risk of scarring with aggressive destruction
- Incomplete removal not guaranteeing permanence
- Development of new lesions over time due to ongoing sebaceous activity
For these reasons, treatment focuses on controlled removal and cosmetic improvement, often using staged approaches rather than a single definitive procedure.
TREATMENT OPTIONS — GENERAL OVERVIEW
No single treatment is universally curative. Recurrence or development of new lesions is common over time.
Procedural / Destructive Options
Punch excision
- Complete removal of individual lesions
- Allows histopathologic confirmation
- Leaves a small linear scar
- Best for solitary or diagnostically uncertain lesions
Shave removal
- Removes raised portion only
- Faster healing but higher recurrence risk
- Possible in select cases; not a preferred method at IVSI
Electrosurgery / electrodessication
- Commonly used in general dermatology
- Not offered at IVSI due to higher risk of scarring and dyspigmentation, particularly on facial skin
Cryotherapy (freezing)
- Variable effectiveness
- Not offered at IVSI due to risk of hypopigmentation, scarring, and unpredictable healing on the face
CO₂ laser ablation
- Precise tissue vaporization
- Reduced procedural bleeding
- Recurrence possible due to deep gland component
LASER & ENERGY-BASED OPTIONS
These methods may reduce lesion prominence or sebaceous activity but rarely eliminate glands entirely.
Pulsed Dye Laser (PDL)
- Targets vascular support to sebaceous glands
- Typically adjunctive rather than definitive
Other vascular or non-ablative lasers
- Variable benefit
- Often used as part of staged treatment
Fractional resurfacing lasers
- Improve overall skin texture
- Not a primary treatment for gland removal
TREATMENT OPTIONS OFFERED AT IVSI
Treatment selection is individualized based on lesion size, depth, location, skin type, diagnostic certainty, and patient goals.
Only methods that balance precision, safety, and predictable healing are offered.
PUNCH EXCISION (SELECT LESIONS)
- Used for large, solitary, or diagnostically uncertain lesions
- Allows complete removal and histopathologic evaluation when needed
- Requires sutures and results in a small linear scar that typically fades over time
CO₂ LASER ABLATION / EVAPORATION
- Used for multiple or raised lesions
- Allows controlled tissue removal with minimal bleeding
- Does not always eliminate the deep gland component
- Recurrence or development of new lesions may occur over time
PULSED DYE LASER (PDL) / Nd:YAG 1064 — ADJUNCTIVE
- Used to reduce vascular support to sebaceous glands
- Non-ablative
- Typically part of a staged treatment plan
- Not a stand-alone treatment for lesion removal
FRACTIONAL RESURFACING (SELECT CASES)
- May be used after lesion removal to improve texture and blending
- Not a primary treatment for sebaceous hyperplasia
In many cases, staged treatment is recommended to achieve the most balanced cosmetic outcome.
ADJUNCTIVE MEDICAL THERAPY (LIMITED ROLE)
Topical retinoids (such as tretinoin) may be recommended in select patients to support epidermal turnover and reduce prominence of new lesions.
Topical therapy does not remove established lesions and is considered supportive rather than definitive.
IMPORTANT CONSIDERATIONS
- Complete and permanent removal of all sebaceous glands is not always possible
- Recurrence or development of new lesions is common
- Aggressive treatment increases scarring risk
- Careful technique selection is essential, especially on facial skin
MEDICAL VS. COSMETIC CARE
Sebaceous hyperplasia is benign. Treatment is most often performed for cosmetic reasons unless diagnostic uncertainty exists.
When lesion appearance is atypical, biopsy or excision may be medically indicated.
Cosmetic treatments are discussed separately, with clear expectations regarding outcomes, recurrence risk, and insurance considerations.
Skin Lesion Evaluation
📞 Call (847) 518-9999 to schedule a skin lesion evaluation
Medical Disclaimer
The information on this page is provided for educational purposes only
and does not replace professional medical evaluation, diagnosis, or treatment.
Treatment recommendations are based on individual clinical findings, diagnostic
testing when indicated, and patient-specific factors. Outcomes may vary,
and no specific medical or cosmetic result can be guaranteed.
Learn More About
